Beasley, Allen, Crow, Methvin, Portis & Miles, P.C.

Canadian pharmaceutical company Janssen-Ortho, Inc. in cooperation with Health Canada has issued a press release updating information on the average daily release rates of contraceptive hormones from the EVRA Transdermal Contraceptive System (patch) that is marketed in Canada and approved for use for the prevention of pregnancy. EVRA is bioequivalent to Ortho Evra, the birth control patch that is marketed in the United States.

Read the rest of this entry »

A new program in Wayne County, Michigan, is giving financially strapped women access to free family planning services, health care and birth control. However, women should be advised to consider their birth control options even if they come at no cost.

Read the rest of this entry »

A British survey suggests one in three women spend no more than five minutes selecting a suitable contraceptive method to use, according to Medical News Today. The report, conducted by Family Planning Association, is part of the organization’s Finding the Perfect Partner (Choose What You Use) campaign to help reduce unplanned pregnancy and abortion, and to promote greater control over contraceptive choice among women and health professionals. It found that despite the seemingly little care women put into the decision of what type of birth control to use, nearly half have had an unwanted pregnancy scare.

Read the rest of this entry »